Close
Nordic 9Nordic 9

LifeArc Ventures (investor - Corporate Investor)

United Kingdom lifearc.org
See something wrong or missing? Let us know
Offices:London

LifeArc Ventures a self-funding medical research charity that invests in Seed and Series-A stage Biotech and Healthtech companies.

Average round investment:39.02M USD
Average number per year:1.8
Distribution: 2025 (3)2024 (1)2023 (2)2021 (1)2020 (2)
Portfolio companies: Switzerland GlycoEraSweden Tribune TherapeuticsUnited Kingdom Maxion Therapeutics See the entire list
Mostly invests in: United Kingdom United Kingdom (7) Health services (9)
See the entire list

Showing 3 of 9 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

LifeArc Ventures mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to LifeArc Ventures

Name Criteria
United States Illumina Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma, Biotech, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Sweden Mellby Gård
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Spain Columbus Venture Partners
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
United States CourtsideVC
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
United States Lux ​​Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Norway Telenor
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
United States Arch Venture Partners
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Sweden
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
Japan Asahi Kasei
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
France Merieux Equity Partners
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Sweden
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
United States Omega Funds
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Top